Drug Discovery

18 Feb 2019
- Drug Discovery
- Research & Development
Decipher announces research collaboration with Dendreon to identify genomic drivers of patient response to Sipuleucel-T

By PBR Staff Writer

Decipher Biosciences (formerly GenomeDx) has announced a research collaboration with Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, to apply genomic tumor profiling using the Decipher assay and GRID software to identify prostate cancer patients on active surveillance who may benefit most from treatment with sipuleucel-T.
18 Feb 2019
Drug Discovery
Research & Development
Artificial intelligence can predict survival of ovarian cancer patients

By PBR Staff Writer

Researchers have created new machine learning software that can forecast the survival rates and response to treatments of patients with ovarian cancer.
15 Feb 2019
Drug Discovery
Research & Development
SK, Arvelle sign $530m deal for antiepileptic drug cenobamate

By PBR Staff Writer

SK Biopharmaceuticals has entered into a $530m deal with the Arvelle Therapeutics for investigational antiepileptic drug cenobamate.
15 Feb 2019
Drug Discovery
Research & Development
Vor Biopharma raises $42m to advance development of cell therapy product candidate for AML

By PBR Staff Writer

Vor Biopharma, an immuno-oncology company pioneering engineered hematopoietic stem cell (HSC) therapies for the treatment of hematological malignancies, has announced a $42m Series A financing round led by 5AM Ventures and RA Capital Management.
13 Feb 2019
Drug Discovery
Pre-clinical Studies
Redx says in vivo data indicates potential of ROCK2 in fibrosis treatment

By PBR Staff Writer

UK based biotech company Redx said that its lead selective ROCK2 compound has been shown to have broad potential in the treatment of fibrosis as per new in vivo data.
12 Feb 2019
Drug Discovery
Research & Development
AbbVie, Teneobio sign deal to develop new treatment for multiple myeloma

By PBR Staff Writer

AbbVie, Teneobio, and its affiliate TeneoOne have entered a global strategic transaction to develop and commercialize TNB-383B, a BCMA-targeting immunotherapeutic for the potential treatment of multiple myeloma.
11 Feb 2019
Drug Discovery
Research & Development
Samsung Bioepis, C-Bridge Capital to develop and commercialize next-generation biosimilars in China

By PBR Staff Writer

Samsung Bioepis has announced its expansion in mainland China through a licensing agreement with C-Bridge Capital.
11 Feb 2019
Drug Discovery
Research & Development
Evotec, Galapagos enter into collaboration in fibrosis field

By PBR Staff Writer

Evotec and Galapagos have announced a global collaboration focused on a novel target for fibrosis and other indications.
08 Feb 2019
Drug Discovery
Research & Development
Ligand announces OmniAb partnership with Genagon Therapeutics

By PBR Staff Writer

Ligand Pharmaceuticals has entered into a worldwide OmniAb partnership with Genagon Therapeutics AB, an immuno-oncology focused biotech located in Sweden.
08 Feb 2019
Drug Discovery
Research & Development
TamRx launches to develop pipeline of immuno-oncology products for treatment of cancers

By PBR Staff Writer

BioMotiv, a drug development accelerator associated with The Harrington Project for Discovery & Development, and researchers from Rutgers, The State University of New Jersey, announced the formation of a new biotech start-up, TamRx.

Drug Discovery

Research & Development

Decipher announces research collaboration with Dendreon to identify genomic drivers of patient response to Sipuleucel-T

Artificial intelligence can predict survival of ovarian cancer patients

Clinical Trials

Patient Enrollment

Newron completes patient enrollment in STARS Study

Vaccinex completes enrollment for SIGNAL Huntington’s disease trial

Regulation

Drug Filing

FDA extends review period for Incyte’s GVHD treatment Jakafi

AstraZeneca’s RSV drug MEDI8897 gets FDA’s breakthrough therapy designation

Production & Sales

Manufacturing

Neuraxpharm acquires CNS specialty pharma company Farmax

Hitachi Chemical to acquire apceth Biopharma

Packaging & Supply Chain

Packaging

PCI Pharma announces bottling line expansion at Rockford site

PCI announces further investment in infrastructure for packaging of controlled substances

Suppliers

No data found

Drug Discovery

Decipher announces research collaboration with Dendreon to identify genomic drivers of patient response to Sipuleucel-T

Artificial intelligence can predict survival of ovarian cancer patients

SK, Arvelle sign $530m deal for antiepileptic drug cenobamate

Vor Biopharma raises $42m to advance development of cell therapy product candidate for AML

Redx says in vivo data indicates potential of ROCK2 in fibrosis treatment

AbbVie, Teneobio sign deal to develop new treatment for multiple myeloma

Samsung Bioepis, C-Bridge Capital to develop and commercialize next-generation biosimilars in China

Evotec, Galapagos enter into collaboration in fibrosis field

Ligand announces OmniAb partnership with Genagon Therapeutics

TamRx launches to develop pipeline of immuno-oncology products for treatment of cancers

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found